Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1937 | Alvocidib | 0.001 | 0.8453 | 0.00981 |
| HCC1937 | Alvocidib | 0.00316227766017 | 1.1652 | 0.00243 |
| HCC1937 | Alvocidib | 0.01 | 0.9890 | 0.00535 |
| HCC1937 | Alvocidib | 0.01 | 0.9527 | 0.05432 |
| HCC1937 | Alvocidib | 0.0316227766017 | 0.9418 | 0.00012 |
| HCC1937 | Alvocidib | 0.1 | 0.6799 | 0.00644 |
| HCC1937 | Alvocidib | 0.1 | 0.7611 | -0.00019 |
| HCC1937 | Alvocidib | 0.316227766017 | 0.1488 | 0.02128 |
| HCC1937 | Alvocidib | 0.316227766017 | 0.1878 | 0.04293 |
| HCC1937 | Alvocidib | 1.0 | -0.2096 | 0.17349 |
| HCC38 | Alvocidib | 0.0001 | 1.0012 | 0.01467 |
| HCC38 | Alvocidib | 0.0001 | 1.1540 | -0.01361 |
| HCC38 | Alvocidib | 0.000316227766017 | 0.9376 | 0.00411 |
| HCC1395 | Alvocidib | 0.0001 | 0.9613 | -0.01557 |
| HCC38 | Alvocidib | 0.001 | 0.9454 | -0.01619 |
| HCC38 | Alvocidib | 0.00316227766017 | 0.9137 | 0.00196 |
| HCC38 | Alvocidib | 0.00316227766017 | 0.8649 | -0.00067 |
| HCC38 | Alvocidib | 0.01 | 1.0625 | -0.01326 |
| HCC38 | Alvocidib | 0.0316227766017 | 0.8247 | 0.00816 |
| HCC38 | Alvocidib | 0.0316227766017 | 0.9811 | -0.00577 |
| HCC38 | Alvocidib | 0.1 | 0.6293 | 0.00383 |
| HCC1395 | Alvocidib | 0.0001 | 1.0356 | -0.02346 |
| HCC38 | Alvocidib | 0.316227766017 | 0.2315 | 0.09752 |
| MDA-MB-134-VI | Alvocidib | 0.001 | 0.4713 | -0.00901 |
| MDA-MB-134-VI | Alvocidib | 0.000316227766017 | 0.9489 | -0.02391 |